Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$RCEL Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$5.00 up 34.21% YoY • Reported revenue of $21.7M up 17.83% YoY • AVITA Medical raised its full-year 2026 net revenue guidance range to $86 million to $89 million, reflecting confidence in continued commercial execution, and expects to reach cash flow breakeven in Q4 2026.
3

Price since post

Full Details

Advertisement|Remove ads.